Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

C-reactive protein: clinical and epidemiological perspectives.

Salazar J, Martínez MS, Chávez M, Toledo A, Añez R, Torres Y, Apruzzese V, Silva C, Rojas J, Bermúdez V.

Cardiol Res Pract. 2014;2014:605810. doi: 10.1155/2014/605810. Review.

3.
4.

High-sensitivity C-reactive protein and atherosclerotic disease: from improved risk prediction to risk-guided therapy.

Koenig W.

Int J Cardiol. 2013 Oct 15;168(6):5126-34. doi: 10.1016/j.ijcard.2013.07.113. Review.

PMID:
23978367
5.

Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events.

Torres JL, Ridker PM.

Curr Opin Cardiol. 2003 Nov;18(6):471-8. Review.

PMID:
14597888
6.

The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease.

Cozlea DL, Farcas DM, Nagy A, Keresztesi AA, Tifrea R, Cozlea L, Carașca E.

Curr Health Sci J. 2013 Oct;39(4):225-31.

7.

C-reactive protein: interaction with the vascular endothelium and possible role in human atherosclerosis.

Ferri C, Croce G, Cofini V, De Berardinis G, Grassi D, Casale R, Properzi G, Desideri G.

Curr Pharm Des. 2007;13(16):1631-45. Review.

PMID:
17584094
8.

[Inflammation and C-reactive protein in cardiovascular disease].

Munk PS, Larsen AI.

Tidsskr Nor Laegeforen. 2009 Jun 11;129(12):1221-4. doi: 10.4045/tidsskr.08.0011. Review. Norwegian.

9.

High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?

Yousuf O, Mohanty BD, Martin SS, Joshi PH, Blaha MJ, Nasir K, Blumenthal RS, Budoff MJ.

J Am Coll Cardiol. 2013 Jul 30;62(5):397-408. doi: 10.1016/j.jacc.2013.05.016. Review.

10.

Markers of inflammation and cardiovascular disease: clinical applications of C-reactive protein determination.

Martínez VB, González-Juanatey JR.

Am J Cardiovasc Drugs. 2009;9 Suppl 1:3-7. doi: 10.2165/1153161-S0-000000000-00000. Review.

PMID:
20000881
11.
12.

Role of inflammation in cardiovascular disease: how to use C-reactive protein in clinical practice.

Zebrack JS, Anderson JL.

Prog Cardiovasc Nurs. 2002 Fall;17(4):174-85. Review.

PMID:
12417833
13.

CRP and the risk of atherosclerotic events.

Calabrò P, Golia E, Yeh ET.

Semin Immunopathol. 2009 Jun;31(1):79-94. doi: 10.1007/s00281-009-0149-4. Review.

PMID:
19415283
14.
15.

High-sensitivity C-reactive protein: a novel cardiovascular risk predictor in type 2 diabetics with normal lipid profile.

Asegaonkar SB, Marathe A, Tekade ML, Cherekar L, Bavikar J, Bardapurkar J, Ajay R.

J Diabetes Complications. 2011 Nov-Dec;25(6):368-70. doi: 10.1016/j.jdiacomp.2011.10.001.

PMID:
22055258
16.

Prognostic value of C-reactive protein for heart disease in dialysis patients.

Wang AY.

Curr Opin Investig Drugs. 2005 Sep;6(9):879-86. Review.

PMID:
16187687
17.

[Fibrinogen. Cardiovascular risk factor or marker?].

Canseco-Avila LM, Jerjes-Sánchez C, Ortiz-López R, Rojas-Martínez A, Guzmán-Ramírez D.

Arch Cardiol Mex. 2006 Oct-Dec;76 Suppl 4:S158-72. Review. Spanish.

PMID:
17469344
18.

C-reactive protein: a nontraditional serum marker of cardiovascular risk.

de Ferranti SD, Rifai N.

Cardiovasc Pathol. 2007 Jan-Feb;16(1):14-21. Review.

PMID:
17218210
19.

Pentraxin 3 in acute respiratory distress syndrome: an early marker of severity.

Mauri T, Coppadoro A, Bellani G, Bombino M, Patroniti N, Peri G, Mantovani A, Pesenti A.

Crit Care Med. 2008 Aug;36(8):2302-8. doi: 10.1097/CCM.0b013e3181809aaf.

PMID:
18596636
Items per page

Supplemental Content

Support Center